20 articles
411-person study shows digital insulin delivery system helps optimize glucose control through automated dose tracking and mobile integration.
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
A completed RCT tests whether small-sided football sessions 3x/week improve glucose control and metabolic health in T2DM patients on GLP-1 and SGLT2 drugs.
Researchers test lipid, glucose, and mixed meal challenges to pinpoint optimal post-meal sample collection windows for future cardiovascular studies.
Study shows intensive glucose management increases cardiac stem cells in heart attack patients, potentially improving recovery.
Danish researchers studied how moderate exercise affects glucose regulation in diabetics versus healthy controls during fasted workouts.
176-person study explored personalized responses to refined carbs, whole grains, and intermittent fasting for optimal glucose control.
Major trial of 10,251 diabetics reveals surprising outcomes from aggressive blood sugar, blood pressure, and cholesterol management.
University of Pennsylvania study tests behavioral tools to help people stick with time-restricted eating for blood pressure and weight management.
Study reveals how newborn care disrupts mothers' circadian rhythms, potentially affecting long-term metabolic health and diabetes risk.
Small study explores whether eating within 9-hour windows can improve blood sugar control and metabolic health in diabetic patients.
Stanford researchers used smartwatches and blood tests to monitor dangerous side effects during cutting-edge CAR-T cancer treatment.
German researchers test whether natural foods plus digital coaching can match diabetes remission rates of formula diets.
Eli Lilly's phase 3 trial pits a novel weekly basal insulin against the gold-standard daily insulin degludec in type 1 diabetes patients.
A Phase 3 trial investigates whether the GLP-1 drug liraglutide can slow cognitive decline in T2DM patients at elevated Alzheimer's risk.
84-person study reveals how targeted nutrition counseling impacts blood sugar, weight, and heart health in diabetic patients.
Small study tests whether combining Mediterranean eating, intermittent fasting, and exercise can reverse diabetes in 6 months.
A completed trial tested whether seismocardiography can accurately estimate VO2max and biological age without exhaustive exercise testing.
70-person trial tested omega-3's effects on irisin and sirtuin-1, key proteins linked to metabolism and aging in diabetic patients.
